Related references
Note: Only part of the references are listed.Long-term Effectiveness of Varicella Vaccine: A 14-Year, Prospective Cohort Study
Roger Baxter et al.
PEDIATRICS (2013)
EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases
Hiroshi Kimura et al.
BLOOD (2012)
Lymphomas differ in their dependence on Epstein-Barr virus
David T. Vereide et al.
BLOOD (2011)
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel
K. L. Munger et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Jeffrey I. Cohen et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
Chrystal U. Louis et al.
JOURNAL OF IMMUNOTHERAPY (2010)
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
Jan D. Luenemann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival
Christoph Mancao et al.
BLOOD (2007)
The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells
Asuka Nanbo et al.
EMBO JOURNAL (2007)
Helicobacter pylori infection and the development of gastric cancer.
N Uemura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
